Skip to content

Device selection trial in endoscopic submucosal dissection for colorectal epitherial neoplasms: A randomized controlled open trial.

Device selection trial in endoscopic submucosal dissection for colorectal epitherial neoplasms: A randomized controlled open trial. - Device selection RCT in colorectal ESD.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001302
Enrollment
50
Registered
2008-08-20
Start date
2008-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal epitherial neoplasm

Interventions

Flex knife group Flush knife group

Sponsors

Osaka Medical Center for Cancer and Cardiovascular Diseases
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Intramucosal or minutes submucosal invaded (SM1) colorectal epitherial neoplasms which are larger than 20mm and smaller than 60mm.

Exclusion criteria

Exclusion criteria: 1) SM massive cancer 2) Lesions which are existed on anal canal or in cecum. 3) Patients with hematological abnormality. 4) Patients with severe organ failure 5) Patients without written informed consent 6) Lesions which were thought to be difficult to resect by ESD because of unstable positioning of colonoscope. 7) Others who were thought to be unsuitable by endoscopist.

Design outcomes

Primary

MeasureTime frame
Procedure time

Countries

Japan

Contacts

Public ContactYoji Takeuchi

Osaka Medical Center for Cancer and Cardiovascular Diseases Gastrointestinal Oncology

takeuti-yo@mc.pref.osaka.jp06-6972-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026